Live Analyst Rating Changes 31643 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Farzin Haque
JEF

Farzin Haque

Jefferies
Wall Street Analyst
★★★★☆
#339
on 13Foresight · ranked by our own returns
62%
Success Rate
+22.3%
Average Return
5 of 8 calls profitable · +90.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 62% of Farzin Haque's ratings turned a profit when each position was held for 1 year — averaging +22.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

6 Buy 1 Hold 0 Sell
Farzin's Stock Coverage 7 ratings · 2026-09-12
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
VOR
Vor Biopharma
 Sep 09, 2026 BUY Buy
+97.3% avg upside
17 analysts
$48.00
115.19% Upside
 +0.0% ·
RLMD
Relmada Therapeutics
 Dec 21, 2025 BUY Buy
+208.9% avg upside
15 analysts
$9.00
99.05% Upside
 -5.3% ·
VERA
Vera Therapeutics
 Nov 26, 2025 BUY Strong Buy
+97.2% avg upside
19 analysts
$45.00
28.37% Upside
 +7.7% ·
RIGL
Rigel
 Nov 05, 2025 BUY Strong Buy
-42.9% avg upside
17 analysts
$42.00
11.12% Downside
 +28.6% ·
NUVB
Nuvation Bio
 Sep 29, 2025 BUY Strong Buy
+118.7% avg upside
17 analysts
$10.00
64.69% Upside
 +111.5% ·
HOWL
Werewolf Therapeutics
 Aug 04, 2025 BUY Strong Buy
+602.6% avg upside
8 analysts
$4.00
307.28% Upside
 -66.5% ·
PYXS
Pyxis Oncology
 Mar 18, 2025 BUY Strong Buy
+149.9% avg upside
15 analysts
$6.00
86.90% Upside
 +44.3% ·
🔒 2 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Farzin Haque — Frequently Asked Questions
How accurate are Farzin Haque's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Farzin's ratings were profitable over a one-year hold, with an average return of +22.3% per rating, or +90.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Farzin ranked on 13Foresight?
Farzin Haque is currently ranked #339 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Farzin cover?
Farzin most recently has ratings on VOR, RLMD, VERA, RIGL, NUVB, HOWL, PYXS. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.